Results 101 to 110 of about 126,625 (144)
, 2015 本研究旨在建立一种基于特征多肽的胶原定量检测方法，通过序列比对的方法筛选胶原蛋白特征多肽，利用胰蛋白酶将牛Ⅰ型胶原蛋白标准品进行酶解，采用液质联用技术(HPLC-MS)对特征多肽进行检测，建立特征多肽丰度与胶原蛋白浓度对应关系并用于实际样品分析。结果表明，牛Ⅰ型胶原蛋白中检测出6种特征多肽，其中多肽GEAGPSGPAGPTGAR由于其丰度高且二级质谱稳定适合作为定量检测的特征多肽，多肽信号强度与蛋白浓度(0.1-3.0 mg/mL)呈良好线性关系。将所建方法用于实际样品分析，牛跟腱胶原蛋白含量为90.2%
孙坤 +8 more
core
[Effect of LncRNA DANCR on the immune microenvironment of glioma cells by regulating the miR-656/BMPR1A axis]. [PDF]
Beijing Da Xue Xue Bao Yi Xue BanWang O, Zhu P, Lin J, Wu H.
europepmc +1 more source
[Interference of P2X4 receptor expression in tumor-associated macrophages suppresses migration and invasion of glioma cells]. [PDF]
Nan Fang Yi Ke Da Xue Xue Bao, 2022 Yang X +9 more
europepmc +1 more source
, 2017 本发明公开了一种透明质酸修饰的聚(N‑异丙基丙烯酰胺‑丙烯酸)水凝胶，首先采用RAFT聚合方法制备聚(N‑异丙基丙烯酰胺‑丙烯酸)水凝胶，然后将聚(N‑异丙基丙烯酰胺‑丙烯酸)水凝胶浸泡在水中，加入1‑(3‑二甲氨基丙基)‑3‑乙基碳二亚胺盐酸盐和N‑羟基丁二酰亚胺反应，最后加入带有肼基基团的透明质酸进行共价固定反应，得到具备较好细胞相容性的透明质酸修饰的聚(N‑异丙基丙烯酰胺‑丙烯酸)水凝胶，并公开该水凝胶在药物控制释放中的应用 ...
肖颖, 侯瑞霞, 付俊
core
[Research Progress in Imaging Investigation of TERT Promoter Mutations in Gliomas]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanZhong Y +5 more
europepmc +1 more source
[Molecular targeted therapy for progressive low-grade gliomas in children]. [PDF]
Zhongguo Dang Dai Er Ke Za ZhiSun YL +9 more
europepmc +1 more source
[circ_EPHB4 synergizes with YTHDF3 to promote glioma progression <i>via</i> m<sup>6</sup>A-dependent stabilization of Wnt3]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoJin C, Liu J, Liu B, Fei X, Liao Y.
europepmc +1 more source
, 2008 本文对沙枣树的出胶,进行了不同创口类型和创口数量与出胶量关系的试验。结果表明:在成龄树的主干上或者老树的树瘤上进行人为创伤制造创口的办法,都可获得较多的出胶量 ...
阿迪力·吾彼尔, 李银芳
core
[Circ_EPHB4 regulates temozolomide sensitivity in glioma cells through the miR-424-5p/Wnt3 axis]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoLiao Y, Liu J, Liu B, Fei X, Jin C.
europepmc +1 more source
, 1994 冠心病心绞痛患者７１３例（男性３９８例，女件３１５例；年龄５８±ｓ６ａ），口服地奥心血康胶囊２００ｍｇ，ｔｉｄ，共２ｍｏ。２ｍｏ后，３９９例继续口服１００ｍｇ，ｔｉｄ，共４ｍｏ。结果：２ｍｏ的临床总有效率为９０．３％，心电图总有效率为５１．７％。该药能明显抑制血小板聚集，降低血胆固醇和甘油三酯 ...
周正质
core